(VIANEWS) – Royal Gold (RGLD), Clearwater Paper Corporation (CLW), Molina Healthcare (MOH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Royal Gold (RGLD)
40.9% sales growth and 10.98% return on equity
Royal Gold, Inc., together with its subsidiaries, acquires and manages precious metal streams, royalties, and related interests. It focuses on acquiring stream and royalty interests or to finance projects that are in production or in development stage in exchange for stream or royalty interests, which primarily consists of gold, silver, copper, nickel, zinc, lead, and cobalt. As of June 30, 2021, the company owned interests in 187 properties on five continents, including interests on 41 producing mines and 17 development stage projects. Its stream and royalty interests on properties are located in the United States, Canada, Chile, the Dominican Republic, Australia, Africa, Mexico, and internationally. Royal Gold, Inc. was incorporated in 1981 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, Royal Gold has a trailing twelve months EPS of $3.65.
PE Ratio
Royal Gold has a trailing twelve months price to earnings ratio of 36.77. Meaning, the purchaser of the share is investing $36.77 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.98%.
Volume
Today’s last reported volume for Royal Gold is 46208 which is 86.36% below its average volume of 338838.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 645.17M for the twelve trailing months.
2. Clearwater Paper Corporation (CLW)
22.9% sales growth and 7.16% return on equity
Clearwater Paper Corporation produces and sells private label tissue and bleached paperboard products in the United States and internationally. The company operates through two segments, Consumer Products, and Pulp and Paperboard. The Consumer Products segment manufactures and sells a line of at-home tissue products, including bath tissues, paper towels, facial tissues, and napkins; recycled fiber value grade products; and away-from-home products and parent rolls. This segment sells its products to retailers and wholesale distributors, including grocery, drug, mass merchants, and discount stores. The Pulp and Paperboard segment manufactures and markets bleached paperboard, folding cartons, liquid packaging, cups and plates, blister and carded packaging, top sheet and commercial printing grades and softwood pulp products, as well as offers custom sheeting, slitting and cutting of paperboard. It sells its products to packaging converters, folding carton converters, merchants, and commercial printers. Clearwater Paper Corporation was incorporated in 2005 and is headquartered in Spokane, Washington.
Earnings Per Share
As for profitability, Clearwater Paper Corporation has a trailing twelve months EPS of $2.63.
PE Ratio
Clearwater Paper Corporation has a trailing twelve months price to earnings ratio of 18.35. Meaning, the purchaser of the share is investing $18.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.16%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 82.8% and a negative 75.3%, respectively.
Moving Average
Clearwater Paper Corporation’s worth is below its 50-day moving average of $50.68 and way above its 200-day moving average of $41.52.
Sales Growth
Clearwater Paper Corporation’s sales growth is 11.8% for the ongoing quarter and 22.9% for the next.
Volume
Today’s last reported volume for Clearwater Paper Corporation is 208132 which is 32.93% above its average volume of 156561.
3. Molina Healthcare (MOH)
12.1% sales growth and 25.12% return on equity
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Earnings Per Share
As for profitability, Molina Healthcare has a trailing twelve months EPS of $18.23.
PE Ratio
Molina Healthcare has a trailing twelve months price to earnings ratio of 18.55. Meaning, the purchaser of the share is investing $18.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.12%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 36.08B for the twelve trailing months.
Previous days news about Molina Healthcare(MOH)
- Compelling reasons to hold molina healthcare (moh) stock now. According to Zacks on Monday, 19 August, "The return on equity for Molina Healthcare is currently 28.1%, which is higher than the industry’s average of 23.9%. ", "This July, Molina Healthcare inked a definitive agreement to purchase ConnectiCare, which is expected to bolster the health insurer’s presence in Connecticut. "
4. Paysign (PAYS)
10.5% sales growth and 35.65% return on equity
PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. It offers various services, such as transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a card processing platform. The company also develops prepaid card programs for corporate incentive and rewards, including consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, it offers Per Diem, Corporate Expense, and Business Travel Cards that allows businesses, and non–profits and government agencies the ability to control employee spending while reducing administration costs by eliminating the need for traditional expense reports. Further, the company provides payment claims processing and other administrative services; pharmacy-based voucher and copay, and medical claims and debit-based affordability programs; PaySign Premier, a demand deposit account debit card; and payment solution for source plasma collection centers, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and Mexico. The company was formerly known as 3PEA International, Inc. and changed its name to PaySign, Inc. in April 2019. PaySign, Inc. was incorporated in 1995 and is headquartered in Henderson, Nevada.
Earnings Per Share
As for profitability, Paysign has a trailing twelve months EPS of $0.15.
PE Ratio
Paysign has a trailing twelve months price to earnings ratio of 29.57. Meaning, the purchaser of the share is investing $29.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.65%.
Volume
Today’s last reported volume for Paysign is 438608 which is 116.96% above its average volume of 202159.
